Indeed, chronic administration of the orally bioavailable mGluR5-selective negative allosteric modulator CTEP reverses cognitive decline in the APPswe/PS1 transgenic mice and reduces Aβ plaque deposition [13]. Here, GRM5 is linked to Mental deterioration.